Press release
United States Propel SGLT-2 Inhibitors Market at 7.1% CAGR on Expanding Cardiorenal Indications
SGLT-2 Inhibitors Market
As per DataM Intelligence research report "SGLT-2 Inhibitors Market reached US$ 17.95 billion in 2024 and is expected to reach US$ 32.16 billion by 2033, growing with a CAGR of 7.1% from 2025 to 2033." Rising prevalence of type 2 diabetes, expanding indications for cardiorenal protection (heart failure and chronic kidney disease), new product approvals, and increasing adoption in emerging markets are fueling growth in the SGLT-2 inhibitors market.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/sglt-2-inhibitors-market?sindhuri
Japan: Recent Industry Developments
✅ In 2025, Mitsubishi Tanabe Pharma launched CANALIA, the first once-daily oral combination of a DPP-4 inhibitor with an SGLT2 inhibitor, enhancing treatment options for type 2 diabetes.
✅ In October 2025, Mitsubishi Tanabe introduced innovative combination therapies in Japan, aligning with national diabetes management programs.
✅ In 2025, Japan saw continued adoption of Japan-specific SGLT2 inhibitors like ipragliflozin (Suglat), supporting precision medicine for cardiometabolic profiles in the aging population.
United States: Recent Industry Developments
✅ In November 2025, Boehringer Ingelheim and Eli Lilly advanced Jardiance expansions with new data reinforcing cardiorenal protection, driving prescription growth.
✅ In September 2025, U.S. HHS initiatives and guideline updates positioned SGLT-2 inhibitors as preferred therapies for comorbid conditions, boosting adoption.
✅ In 2025, positive trial results for INPEFA (sotagliflozin) demonstrated a 23% reduction in heart attacks, strokes, and cardiovascular mortality in heart failure patients.
SGLT-2 Inhibitors Market: Drivers
The SGLT-2 inhibitors market is driven by the rising prevalence of type 2 diabetes, increasing research and development activities, and new product launches. Expanding indications beyond glycemic control to include heart failure and chronic kidney disease (CKD), proven cardiorenal benefits, guideline recommendations, and growing market access in emerging countries further accelerate adoption. Rising awareness of multi-organ protection and supportive regulatory approvals sustain momentum amid the global burden of cardiometabolic diseases.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/sglt-2-inhibitors-market?sindhuri
SGLT-2 Inhibitors Market: Major Players
TheracosBio, LLC, Johnson & Johnson Services, Inc., AstraZeneca, Boehringer Ingelheim International GmbH., Eli Lilly and Company., Pfizer Inc., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc.
Segment Covered in the SGLT-2 Inhibitors Market:
By Drug Type
Bexagliflozin, Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Sotagliflozin.
By Indication
Type-2 Diabetes, Chronic Kidney Disease (CKD), Heart Failure.
By Distribution Channel
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Regional Analysis
North America - Dominant Share
North America leads with a significant share of 41.9% in 2024, driven by high diabetes prevalence, advanced healthcare infrastructure, early regulatory approvals, and strong adoption for cardiorenal indications.
Asia Pacific - Fastest-Growing
Asia Pacific expands rapidly with the highest CAGR, fueled by rising diabetes cases, urbanization, improving healthcare access, and local innovations.
Europe - Significant Share
Europe grows with emphasis on evidence-based guidelines and cardiorenal protection benefits.
South America - Gradual Growth
South America shows steady progress amid increasing diabetes awareness and healthcare investments.
Middle East & Africa - Emerging Growth
Middle East & Africa rises with growing chronic disease burden and expanding pharmaceutical access.
Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=sglt-2-inhibitors-market&sindhuri
(Purchase 2 or more Reports and get 50% Discount)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Propel SGLT-2 Inhibitors Market at 7.1% CAGR on Expanding Cardiorenal Indications here
News-ID: 4340845 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Crypto Asset Management Market Outlook, Technology Evolution, and Growth Opportu …
The global crypto asset management market reached around US$ 1.74 billion in 2023, increased to approximately US$ 1.89 billion in 2024, and is projected to hit about US$ 15.87 billion by 2033, reflecting a strong CAGR of nearly 26.7% during 2025-2033. This robust trajectory is underpinned by accelerating institutional participation, stronger regulatory frameworks, and rapid innovation across custody, trading, and analytics platforms.
Crypto Asset Management refers to the professional management of…
India Semiconductor Manufacturing Market to Reach USD 132.11 Billion by 2033, Fu …
The India semiconductor manufacturing market reached US$ 49.41 billion in 2023, rising to US$ 54.14 billion in 2024, and is expected to hit US$ 132.11 billion by 2033, growing at a CAGR of 10.42% during 2025-2033. This explosive growth is driven by surging domestic demand for electronics, government initiatives like the Production-Linked Incentive (PLI) scheme, and adoption of 5G, IoT, EVs, and data centers.
India's semiconductor manufacturing sector is emerging as…
Software-Defined Wide Area Network (SD-WAN) Market to Reach USD 18.58 Billion by …
The global software-defined wide area network (SD-WAN) market reached USD 8.86 billion in 2024 and is expected to reach USD 18.58 billion by 2032, growing with a CAGR of 12.2% during the forecast period 2025-2032. This growth is propelled by rapid digital transformation, cloud adoption, and demand for secure, agile networking to support SaaS, hybrid workforces, and multi-cloud strategies.
Software-Defined Wide Area Network (SD-WAN) is a networking technology that uses software-based…
RegTech Market to Reach USD 33.36 Billion by 2032, Driven by AI Compliance and R …
The global RegTech market is valued at USD 20.04 billion in 2024 and is projected to attain USD 33.36 billion by 2032, expanding at a CAGR of 6.75% during 2025-2032. This growth addresses escalating regulatory demands, cyber threats, and the need for efficient compliance in financial services, leveraging AI, blockchain, and cloud technologies.
RegTech (Regulatory Technology) refers to the application of advanced digital technologies to help organizations manage regulatory compliance efficiently.…
More Releases for Inhibitors
Thymidine Phosphorylase Inhibitors Market - Breaking the Cycle: Angiogenesis Inh …
Newark, New Castle, USA: The "Thymidine Phosphorylase Inhibitors Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Thymidine Phosphorylase Inhibitors Market: https://www.growthplusreports.com/report/thymidine-phosphorylase-inhibitors-market/8826
This latest report researches the industry structure,…
CGRP Inhibitors Market - Break Free from Migraine: CGRP Inhibitors Redefining Re …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global CGRP Inhibitors Market.
CGRP Inhibitors Market: https://www.growthplusreports.com/report/cgrp-inhibitors-market/9155
The CGRP Inhibitors Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity.
The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab…
